WINSTON PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • November 13th, 2009 • Winston Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 13th, 2009 Company Industry JurisdictionWinston Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants this 25th day of September, 2009 (the “Grant Date”), to _____ (the “Optionee”), an option, pursuant to the Winston Pharmaceuticals, Inc. Omnibus Incentive Plan (the “Plan”), to purchase a maximum of _____ (_____) shares of the Company’s Common Stock, at the price of $1.36 per share (or such price as is subsequently determined by the Internal Revenue Service for the purposes of avoiding penalties under Code Section 409A to be the Fair Market Value as of the Grant Date pursuant to Treasury Regulations Section 1.409A-1(b)(5)(iv)(B), if applicable), on the following terms and conditions:
WINSTON PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • April 17th, 2009 • Winston Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 17th, 2009 Company Industry JurisdictionWinston Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants this 7th day of April, 2009 (the “Grant Date”), to (the “Optionee”), an option, pursuant to the Winston Pharmaceuticals, Inc. Omnibus Incentive Plan (the “Plan”), to purchase a maximum of ( ) shares of the Company’s Common Stock, at the price of $1.53 per share (or such price as is subsequently determined by the Internal Revenue Service for the purposes of avoiding penalties under Code Section 409A to be the Fair Market Value as of the Grant Date pursuant to Treasury Regulations Section 1.409A-1(b)(5)(iv)(B), if applicable), on the following terms and conditions: